CNR1 and inflammatory bowel disease: The classical cannabinoid receptor CNR1, as well as the transient receptor potential channels TRPV1 and TRPV3 are considered targets for endocannabinoid compounds [53], and, in this study, we show a downregulation of these receptors in IBD.